Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia

Journal of Infection and Chemotherapy

Volumn 12, Issue 3, 2006, Pages 148-151

  Saito, Takeshi ^a   Asai, Osamu ^a   Dobashi, Nobuaki ^a   Yano, Shingo ^a   Osawa, Hiroshi ^a   Takei, Yutaka ^a   Takahara, Shinobu ^a   Ogasawara, Yoji ^a   Yamaguchi, Yuko ^a   Minami, Jiro ^a   Usui, Noriko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myeloid leukemia; Ara C; Cytosine arabinoside; Peripheral neuropathy; Side effect

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; METHYLPREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DRUG MEGADOSE; ELECTROMYOGRAM; FOOT; GRAFT VERSUS HOST REACTION; HUMAN; LIMB WEAKNESS; MALE; NERVE CONDUCTION; NEUROTOXICITY; PARESTHESIA; PERIPHERAL NEUROPATHY; PERONEUS NERVE; SYMPTOMATOLOGY; TREATMENT DURATION; WHOLE BODY RADIATION;

EID: 33745781869     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-006-0443-1     Document Type: Article

References (13)

1. WJ Baker GL Royer RB Weiss 1991 Cytarabine and neurologic toxicity J Clin Oncol 9 679 93
2. JC Byrd RK Dodge A Carroll MR Baer C Edwards J Stamberg 1999 Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered J Clin Oncol 17 3767 75
3. B Scherokman MR Filling-Katz D Tell 1985 Brachial plexus neuropathy following high-dose cytarabine in acute monoblastic leukemia Cancer Treat Rep 69 1005 6
4. BL Powell RL Capizzi ES Lyerly MR Cooper 1986 Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia J Clin Oncol 4 95 7
5. A Borgeat B DeMuralt M Stalder 1986 Peripheral neuropathy associated with high-dose Ara-C therapy Cancer 58 852 4
6. NT Johnson SW Crawford M Sargur 1987 Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation Bone Marrow Transplant 2 203 7
7. TJ Nevill TJ Benstead CW [tmp] McCormick OA Hayne 1989 Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside Am J Hematol 32 314 5
8. M Paul D Joshua N Rahme J Pollard J Ell J Gibson 1991 Fatal peripheral neuropathy associated with axonal degeneration after high-dose cytosine arabinoside in acute leukemia Br J Haematol 79 521 3
9. H Openshaw NE Slatkin AS Stein DR Hinton SJ Forman 1996 Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia Cancer 78 1899 905
10. MD Winkelman JD Hines 1996 Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study Ann Neurol 14 520 7
11. AJ Aguayo JS Romine GM Bray 1975 Experimental necrosis and arrest of proliferation of Schwann cells by cytosine arabinoside J Neurocytol 4 663 74
12. L Montalbetti G Brambilla Pisoni G Trotti MV Calloni 1992 Polyneuritis after HD Ara-C therapy for malignant lymphoma Ital J Neurol 13 85
13. D Machover B Delmas-Marsalet SC Misra Y Gumus E Goldschmidt A Schilf 2001 Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma Ann Oncol 12 1439 43